We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$100M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$97M
3
LRCX icon
Lam Research
LRCX
+$85.4M
4
BSX icon
Boston Scientific
BSX
+$79.4M
5
MRK icon
Merck
MRK
+$67M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNRHW
576
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$74K ﹤0.01%
409,487
– –
RVACW
577
DELISTED
Riverview Acquisition Corp. Warrant
RVACW
$71K ﹤0.01%
150,000
– –
AAQC.WS
578
DELISTED
Accelerate Acquisition Corp Warrants
AAQC.WS
$64K ﹤0.01%
166,666
– –
CVIIW
579
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$60K ﹤0.01%
100,000
– –
AGGRW
580
DELISTED
Agile Growth Corp Warrant
AGGRW
$60K ﹤0.01%
199,999
– –
ADTHW
581
DELISTED
AdTheorent Holding Co Warrants
ADTHW
$59K ﹤0.01%
41,666
– –
COCHW icon
582
Envoy Medical Warrant
COCHW
$56K ﹤0.01%
224,999
+66,666
+42% +$28.7K
CCAIW
583
DELISTED
Cascadia Acquisition Corp. Warrant
CCAIW
$56K ﹤0.01%
150,000
– –
HIIIW
584
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$55K ﹤0.01%
139,001
+59,001
+74% +$29.5K
CNDA.WS
585
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$52K ﹤0.01%
100,000
– –
BOAS.WS
586
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$50K ﹤0.01%
187,000
+166,167
+798% +$64.1K
MIT.WS
587
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$49K ﹤0.01%
148,333
+75,000
+102% +$31.8K
ZLSWW
588
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$48K ﹤0.01%
118,071
– –
OSI.WS
589
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$47K ﹤0.01%
225,000
– –
FRONW
590
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
$47K ﹤0.01%
87,500
– –
ESM.WS
591
DELISTED
ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ESM.WS
$47K ﹤0.01%
116,666
– –
BACA.WS
592
DELISTED
Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50
BACA.WS
$41K ﹤0.01%
+150,000
New +$53K
AONCW
593
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$40K ﹤0.01%
100,000
– –
MBSC.WS
594
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
$39K ﹤0.01%
+156,300
New +$61K
HHLA.WS
595
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$37K ﹤0.01%
150,000
– –
LGACW
596
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$37K ﹤0.01%
70,000
– –
ATEK.WS
597
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$35K ﹤0.01%
+175,000
New +$60.4K
PHYT.WS
598
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$34K ﹤0.01%
+75,000
New +$34.7K
PDOT.WS
599
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$34K ﹤0.01%
90,000
– –
BTMDW
600
DELISTED
Biote Corp. Warrant
BTMDW
$33K ﹤0.01%
59,428
+21,928
+58% +$10.4K
22 23
24
25 26

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.